Background Accurate detection and morphology evaluation of unruptured intracranial aneurysms (UIAs) are essential for patient management. This study aimed to assess the efficacy of ...
Surgical ventriculoperitoneal shunting remains standard treatment for communicating hydrocephalus, despite persistently elevated infection and revision rates. A novel minimally invasive endovascular ...
Background The benefit of best medical treatment including intravenous alteplase (IVT) before mechanical thrombectomy (MT) in patients with acute ischemic stroke and extensive early ischemic changes ...
Background and objectives Intracranial wide neck bifurcation aneurysms treated with intrasaccular devices can have recurrences, with adverse morphologies, that are challenging to manage. We report our ...
Correspondence to Dr Ansaar T Rai, Department of Interventional Neuroradiology, West Virginia University, Room 2278, HSCS, P.O. Box 9235, Morgantown, WV 26506, USA; ansaar.rai{at}gmail.com Background ...
Background Venous sinus stenting (VSS) has been shown to reduce intracranial venous pressures and improve symptoms in patients with idiopathic intracranial hypertension (IIH). However, long-term ...
Background Although aspiration and stent retriever thrombectomy perform similarly in proximal occlusions, no comparative series are available in distal occlusions. We aimed to compare the 3 mm Trevo ...
Background Preliminary clinical studies on the safety and efficacy of the pipeline embolization device (PED) for the treatment of small/medium aneurysms have demonstrated high occlusion rates with low ...
Correspondence to Dr Federico Cagnazzo, Neuroradiology, Centre Hospitalier Regional Universitaire de Montpellier, 34295 Montpellier, France; f.cagnazzo86{at}gmail.com Background Evidence about the ...
Correspondence to Professor David Fiorella, Cerebrovascular Center, Department of Neurosurgery, Stony Brook University Medical Center,101 Nicolls Road, Stony Brook, New York 11790631 444 2772, USA; ...
Background Untreated ischemic stroke can lead to severe morbidity and death, and as such, there are numerous endovascular blood-clot removal (thrombectomy) devices approved for human use. Human ...
Background Semaglutide (Ozempic) has been widely used for glycemic control and cardiovascular protection in patients with type 2 diabetes. However, its impact on outcomes in patients with acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback